CAS 2057509-72-3

Fórmula: C22H28ClN5O2

InChI: InChI=1S/C22H28ClN5O2/c1-13(29)26-15-6-4-5-14(7-15)21(30)27-20-8-16(18(23)11-24-20)17-10-25-28-12-22(2,3)9-19(17)28/h8,10-11,14-15H,4-7,9,12H2,1-3H3,(H,26,29)(H,24,27,30)/t14-,15+/m0/s1

Chave InChI: AVIWDYSJSPOOAR-LSDHHAIUSA-N

SMILES: CC(=O)N[C@@H]1CCC[C@@H](C1)C(=O)NC2=NC=C(C(=C2)C3=C4CC(CN4N=C3)(C)C)Cl

AZD4573

CAS: 2057509-72-3

AZD4573

Fórmula: C₂₂H₂₈ClN₅O₂

Pureza: ≥98%

Peso molecular: 429.94

Ref: 54-BUP07031

AZD4573

CAS: 2057509-72-3

(1S,3R)-3-Acetamido-N-(5-chloro-4-(5,5-dimethyl-5,6-dihydro-4H-pyrrolo[1,2-b]pyrazol-3-yl)pyridin-2-yl)cyclohexanecarboxamide

Fórmula: C₂₂H₂₈ClN₅O₂

Pureza: 99%

Peso molecular: 429.94

Ref: IN-DG00779618

AZD4573

Produto Controlado

CAS: 2057509-72-3

Fórmula: C₂₂H₂₈ClN₅O₂

Cor e Forma: Neat

Peso molecular: 429.94

Ref: TR-A808275

AZD 4573

CAS: 2057509-72-3

Cyclin-dependent kinase 9 (CDK9) inhibitor

Fórmula: C₂₂H₂₈ClN₅O₂

Pureza: Min. 95%

Peso molecular: 429.94 g/mol

Ref: 3D-BA166454

AZD4573

CAS: 2057509-72-3

AZD4573 is an effective and selective CDK9 inhibitor (IC50: <4 nM). It enables transient target engagement for the treatment of hematologic malignancies.

Fórmula: C₂₂H₂₈ClN₅O₂

Pureza: 99% - 99.51%

Cor e Forma: Solid

Peso molecular: 429.94

Ref: TM-T10436